An2 Therapeutics Inc

ANTXNASDAQ · US

Holders

ACQUIREDT+30
Trenor Cameron C. III
An2 Therapeutics Inc · NASDAQ
+116,667 sh
Filed 16 Sept 2026SEC Form 4view source
REDUCEDStale
Readnour Robin Shane
An2 Therapeutics Inc · NASDAQ
−523 sh · $3.2K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Readnour Robin Shane
An2 Therapeutics Inc · NASDAQ
−585 sh · $3.5K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Readnour Robin Shane
An2 Therapeutics Inc · NASDAQ
−2,877 sh · $17.5K
Filed 8 Sept 2026SEC Form 4view source
REDUCEDStale
Readnour Robin Shane
An2 Therapeutics Inc · NASDAQ
−3,223 sh · $19.6K
Filed 8 Sept 2026SEC Form 4view source
REDUCEDStale
Readnour Robin Shane
An2 Therapeutics Inc · NASDAQ
−5,294 sh · $31.9K
Filed 8 Sept 2026SEC Form 4view source
REDUCEDStale
Readnour Robin Shane
An2 Therapeutics Inc · NASDAQ
−4,725 sh · $28.4K
Filed 8 Sept 2026SEC Form 4view source
REDUCEDStale
Williams Sarah Joanne
An2 Therapeutics Inc · NASDAQ
−272 sh · $1.5K
Filed 4 Sept 2026SEC Form 4view source
ACQUIREDStale
FitzPatrick Margaret M
An2 Therapeutics Inc · NASDAQ
+2,098 sh · $11.6K
Filed 2 Sept 2026SEC Form 4view source
REDUCEDStale
Readnour Robin Shane
An2 Therapeutics Inc · NASDAQ
−18,706 sh · $112.4K
Filed 19 Aug 2026SEC Form 4view source